Literature DB >> 8158056

Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis.

G Cozon1, F Biron, M Jeannin, D Cannella, J P Revillard.   

Abstract

Immune mechanisms that may control Cryptosporidium parvum infection remain unknown. The role of T cell-mediated immunity is suggested by the chronic disease observed in AIDS patients and in athymic or CD4+ T cell-depleted mice. The role of specific antibodies is also unclear. This study sought to determine serum and secretory antibodies to C. parvum in patients infected with human immunodeficiency virus type 1 (HIV-1) with or without chronic cryptosporidiosis. C. parvum-specific antibodies and specific secretory antibodies were determined by ELISA in saliva and sera from 50 HIV-1-infected patients, 27 healthy adults, and 21 healthy children. Despite lower CD4+ lymphocyte counts, patients with chronic cryptosporidiosis had increased levels of C. parvum-specific antibodies in saliva and serum and higher specific secretory antibody levels in saliva than did controls. Persistence of protracted diarrhea despite high levels of both serum and secretory antibodies suggests that specific secretory antibodies are not sufficient to control this protozoan parasite infection of intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158056     DOI: 10.1093/infdis/169.3.696

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 2.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

Review 3.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Recent diarrhea is associated with elevated salivary IgG responses to Cryptosporidium in residents of an eastern Massachusetts community.

Authors:  A I Egorov; L M Montuori Trimble; L Ascolillo; H D Ward; D A Levy; R D Morris; E N Naumova; J K Griffiths
Journal:  Infection       Date:  2010-03-26       Impact factor: 3.553

5.  Fecal antibodies to Cryptosporidium parvum in healthy volunteers.

Authors:  S M Dann; P C Okhuysen; B M Salameh; H L DuPont; C L Chappell
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 7.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

8.  Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients.

Authors:  Kirti Kaushik; Sumeeta Khurana; Ajay Wanchu; Nancy Malla
Journal:  BMC Infect Dis       Date:  2009-11-18       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.